I20 I21 I22 I23 I24 I25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Participant is willing and able to give informed consent for participation in the study - Angiogram shows haemodynamically relevant complex lesion (ACC–AHA class B2/C) suitable for PCI and suitable for the use of intravascular imaging (OCT)
Exclusion criteria
Exclusion criteria: The participant may not enter the study if ANY of the following are known to apply: - Patients in whom safety or clinical concerns preclude participation. - ST elevation myocardial infarction - Anaemia (Hb < 7 mmol/l) - Pregnancy, trying for a baby or breast feeding - Revascularization by mean of balloon angioplasty without stenting - Known severe renal failure (eGFR < 30 ml/min/1.73m2) or history of dialysis or renal transplant - Presentation with cardiogenic shock - Unconscious on presentation - Contraindications to adenosine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the impact of a study specific treatment algorithm on final FFR after PCI measured in the target vessel: - baseline versus proportion of patient with FFR measured at the end of optimisation procedure (final FFR) | — |
Secondary
| Measure | Time frame |
|---|---|
| The MD-OPCI study aims to assess the frequency of intracoronary pathologies after PCI that potentially lead to an impaired FFR using OCT according to CLI-OPCI II study criteria: 1. Frequency of: - Stent-edge dissection - Geographical miss/Reference lumen narrowing - Stent-malapposition - In-stent minimum lumen area (MLA) < 4.5 mm2 - In-stent MLA <70% of the average reference lumen area - Intrastent plaque/thrombus protrusion 2. Frequency of a significant pressure step up during pressure wire pullback during maximal hyperaemia. | — |
Countries
Germany
Contacts
Universitätsklinik für Kardiologie und Angiologie